The institutional foundations of Muscular Dystrophy Pakistan were built in 2021 by its founder, Ghulam Ali, whose work stems from a deep personal history with Limb-Girdle Muscular Dystrophy Type R1 (LGMDR1). The initial clinical signs appeared unexpectedly in 2007 at the age of 18 during a local village cricket match, where an unprompted fall while fielding a high catch signaled early neuromuscular changes. Throughout his university years at the University of Sindh, Jamshoro, where he studied Rural Development, these progression tracks gradually became more explicit.
By his second academic tenure, standard physical tasks like standing up from a seated position on the floor, stair ascension, or distance walking began to manifest deep muscular fatigue and a burning sensation in his lower limbs. Following complex neurological evaluations, MRI, and electromyography (EMG) tests at the Liaquat University Hospital in Hyderabad, a formal diagnosis of chronic Muscular Dystrophy was recorded, though clinical paths remained restricted strictly to supportive management protocols.
Refusing to let the lack of diagnostic networks limit patient horizons in Pakistan, Ghulam Ali initiated rigorous genetic data tracking in 2016. By 2021, he successfully mapped a precise multi-gene confirmation establishing LGMDR1. This milestone led to the formal creation of Muscular Dystrophy Pakistan to serve as a centralized framework providing molecular diagnostics, policy alignment, and clinical guidance so that no rare disease family walks this road alone.
